Literature DB >> 24337068

Actin-binding protein, Espin: a novel metastatic regulator for melanoma.

Takeshi Yanagishita1, Ichiro Yajima, Mayuko Kumasaka, Yoshiyuki Kawamoto, Toyonori Tsuzuki, Yoshinari Matsumoto, Daisuke Watanabe, Masashi Kato.   

Abstract

UNLABELLED: Espin is a multifunctional actin-bundling protein with multiple isoforms, and has special connections to hair cell stereocilia and microvillar specializations of sensory cells in the inner ear. However, there have been no reports showing the expression and function of Espin in cancers, including melanoma. Here, it is demonstrated that Espin expression is significantly increased in melanomas that spontaneously developed in RET-transgenic mice (RET-mice). Importantly, the invasion capacity of Espin-depleted Mel-ret melanoma cells derived from a tumor of the RET-mouse was dramatically less than that of control melanoma cells with reductions of lamellipodia, focal adhesion kinase (FAK), and GTP-Rac1 activities. Correspondingly, the ratio of metastatic foci in Espin-depleted Mel-ret melanoma cells was significantly less than that of control melanoma cells in an in vivo melanoma metastasis model. Moreover, Espin could be a novel biomarker of melanoma in humans, because our immunohistochemical analysis data reveal that percentages of Espin-positive cells in human primary and metastatic melanomas were significantly higher than that of cells in melanocytic nevi. Together, these results indicate that Espin is not only a metastatic regulator for melanoma but also a potential biomarker of disease progression. IMPLICATIONS: Actin-binding protein Espin is expressed in melanoma, affects metastasis, and is a potential target for melanoma therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24337068     DOI: 10.1158/1541-7786.MCR-13-0468-T

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  8 in total

1.  An actin-binding protein espin is a growth regulator for melanoma.

Authors:  Takeshi Yanagishita; Ichiro Yajima; Mayuko Kumasaka; Machiko Iida; Li Xiang; Yasuhiko Tamada; Yoshinari Matsumoto; Daisuke Watanabe; Masashi Kato
Journal:  J Invest Dermatol       Date:  2014-06-17       Impact factor: 8.551

2.  GNG2 inhibits invasion of human malignant melanoma cells with decreased FAK activity.

Authors:  Ichiro Yajima; Mayuko Y Kumasaka; Osamu Yamanoshita; Cunchao Zou; Xiang Li; Nobutaka Ohgami; Masashi Kato
Journal:  Am J Cancer Res       Date:  2014-03-01       Impact factor: 6.166

Review 3.  Actin-Binding Proteins as Potential Biomarkers for Chronic Inflammation-Induced Cancer Diagnosis and Therapy.

Authors:  Yu-Gui Zhang; Jiang-Tao Niu; Hong-Wei Wu; Xin-Lei Si; Shu-Juan Zhang; Dong-Hui Li; Tian-Tian Bian; Yue-Feng Li; Xing-Ke Yan
Journal:  Anal Cell Pathol (Amst)       Date:  2021-06-05       Impact factor: 2.916

4.  Deltex-3-like (DTX3L) stimulates metastasis of melanoma through FAK/PI3K/AKT but not MEK/ERK pathway.

Authors:  Nguyen Dinh Thang; Ichiro Yajima; Mayuko Y Kumasaka; Machiko Iida; Tamio Suzuki; Masashi Kato
Journal:  Oncotarget       Date:  2015-06-10

5.  An actin-binding protein ESPN is an independent prognosticator and regulates cell growth for esophageal squamous cell carcinoma.

Authors:  Shau-Hsuan Li; Hung-I Lu; Wan-Ting Huang; Yen-Hao Chen; Chien-Ming Lo; Ya-Chun Lan; Wei-Che Lin; Hsin-Ting Tsai; Chang-Han Chen
Journal:  Cancer Cell Int       Date:  2018-12-29       Impact factor: 5.722

6.  E3 ubiquitin ligase ASB17 is required for spermiation in mice.

Authors:  Cong Shen; Jinfu Xu; Qiao Zhou; Meng Lin; Jinxing Lv; Xi Zhang; Yangyang Wu; Xia Chen; Jun Yu; Xiaoyan Huang; Bo Zheng
Journal:  Transl Androl Urol       Date:  2021-12

7.  Transcription factor LSF (TFCP2) inhibits melanoma growth.

Authors:  Yuji Goto; Ichiro Yajima; Mayuko Kumasaka; Nobutaka Ohgami; Asami Tanaka; Toyonori Tsuzuki; Yuji Inoue; Satoshi Fukushima; Hironobu Ihn; Mikiko Kyoya; Hiroyuki Ohashi; Tamihiro Kawakami; Dorothy C Bennett; Masashi Kato
Journal:  Oncotarget       Date:  2016-01-19

8.  Overexpression of microRNA-612 Restrains the Growth, Invasion, and Tumorigenesis of Melanoma Cells by Targeting Espin.

Authors:  Ying Zhu; Hao-Liang Zhang; Qi-Ying Wang; Min-Jing Chen; Lin-Bo Liu
Journal:  Mol Cells       Date:  2018-01-29       Impact factor: 5.034

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.